Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Reductive Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118324765A reveals a novel Ir-catalyzed route for Duvelisib, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN116924916B details a novel catalyst-free reductive amination method offering high selectivity and supply chain stability for pharmaceutical intermediates manufacturing.
Novel Amberlyst 15 catalyzed route for Bisolvon reduces toxicity and steps. Offers cost reduction in pharmaceutical manufacturing and high-purity API intermediate supply.
Patent CN108640884B details a cost-effective 2-morpholinone synthesis. Discover high-purity pharmaceutical intermediates and scalable manufacturing solutions.
Patent CN108178761A reveals a mild PtO2 catalytic route for Sitagliptin. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113583992A reveals a novel RsRedAm enzyme for efficient secondary amine synthesis, offering mild conditions and high selectivity for pharmaceutical intermediates.
Patent CN111689933B details a green one-pot reductive amination using biomass-derived HMF and nitrobenzene, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel chiral induction method for Rotigotine intermediate. Reduces cost and improves scalability for pharmaceutical manufacturing supply chains globally.
Patent CN117756644A reveals a novel method converting caprolactam by-products into high-purity N-hexylcyclohexylamine, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Discover the novel cobalt-catalyzed reductive amination route for Vonoprazan Fumarate. Enhanced yield, simplified process, and cost-effective manufacturing for global supply chains.
Advanced synthesis of chiral tetrahydroquinoline derivatives via diastereomeric resolution. Reliable supplier for scalable API intermediates with optimized cost structures.
Novel intermediates for antidiabetic agents. Optimized synthesis routes reduce costs and improve supply chain reliability for global pharmaceutical manufacturers.
Patent CN117003647A details a Ru-Co alloy catalyst for low-temperature reductive amination, offering high yield and cost efficiency for pharmaceutical intermediate manufacturing.
Discover a novel, high-yield synthesis route for Prucalopride intermediates via reductive amination. Optimize your supply chain with cost-effective pharmaceutical manufacturing solutions.
High-yield reductive amination route for Elagolix intermediate. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturing.
Patent CN115651043A reveals a streamlined one-step synthesis for PNU-159682 derivatives, offering cost reduction and scalable supply chain solutions for ADC manufacturing.
Patent CN106866574A reveals palladium-catalyzed asymmetric reductive amination for high-purity chiral sulfonamides, offering supply chain reliability and cost efficiency.
Patent CN110668958A reveals a high-purity synthesis route for (R)-3-aminobutanol, a key Dolutegravir intermediate, offering significant cost and supply chain advantages.
Novel reductive amination route for influenza inhibitor intermediate. High yield, safe scale-up, and cost-effective pharmaceutical manufacturing solutions.
Patent CN104263797A details a high-yield enzymatic resolution process for R-1-aminotetralin, offering significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.